{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:21:12Z","timestamp":1790418072263,"version":"4.1.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.metabol.2022.155179","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T10:56:39Z","timestamp":1646909799000},"page":"155179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1862-6461","authenticated-orcid":false,"given":"Theodor","family":"Baars","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Gieseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polykarpos C.","family":"Patsalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6069-7899","authenticated-orcid":false,"given":"Ali","family":"Canbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2022.155179_bb0005","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1080\/14656566.2020.1744564","article-title":"Current and new pharmacotherapy options for non-alcoholic steatohepatitis","volume":"21","author":"Sumida","year":"2020","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.metabol.2022.155179_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20070311","article-title":"Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis","volume":"115","author":"Loria","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.metabol.2022.155179_bb0015","article-title":"Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease","volume":"111S","author":"Long","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155179_bb0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","article-title":"Epidemiology of non-alcoholic and alcoholic fatty liver diseases","volume":"5","author":"Mitra","year":"2020","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155179_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155179_bb0030","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2006.08.021","article-title":"Non-alcoholic fatty liver disease and increased risk of cardiovascular disease","volume":"191","author":"Targher","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2022.155179_bb0035","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2022.155179_bb0040","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2022.155179_bb0045","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2022.155179_bb0050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jhep.2020.12.025","article-title":"Yet more evidence that MAFLD is more than a name change","volume":"74","author":"Eslam","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2022.155179_bb0055","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3748\/wjg.v13.i10.1579","article-title":"Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease","volume":"13","author":"Hamaguchi","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2022.155179_bb0060","first-page":"201","article-title":"Prevalence of non-alcoholic fatty liver disease in patients with coronary artery disease","volume":"12","author":"Baharvand-Ahmadi","year":"2016","journal-title":"ARYA Atheroscler"},{"key":"10.1016\/j.metabol.2022.155179_bb0065","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cgh.2011.12.039","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population","volume":"10","author":"Stepanova","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155179_bb0070","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2022.155179_bb0075","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease \u2013 a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2022.155179_bb0080","unstructured":"Cardiovascular diseases. World Health Organization, https:\/\/www.who.int\/health-topics\/cardiovascular-diseases#tab=tab_1 [accessed 21 February 2021]."},{"key":"10.1016\/j.metabol.2022.155179_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1464-5491.2007.02025.x","article-title":"Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens","volume":"24","author":"Targher","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2022.155179_bb0090","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.2337\/diabetes.54.12.3541","article-title":"Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients","volume":"54","author":"Targher","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2022.155179_bb0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1464-5491.2006.01817.x","article-title":"Increased prevalence of cardiovascular disease in type 2 diabetic patients with non-alcoholic fatty liver disease","volume":"23","author":"Targher","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/j.metabol.2022.155179_bb0100","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.3390\/ijerph16173104","article-title":"Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications","volume":"16","author":"Tana","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.metabol.2022.155179_bb0105","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1053\/j.gastro.2015.05.044","article-title":"Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease","volume":"149","author":"du Plessis","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2022.155179_bb0110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/1570161115666170621082910","article-title":"Statins: an under-appreciated asset for the prevention and the treatment of NAFLD or NASH and the related cardiovascular risk","volume":"16","author":"Athyros","year":"2018","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.metabol.2022.155179_bb0115","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/apt.16016","article-title":"Patterns and predictors of mortality and disease progression among patients with non-alcoholic fatty liver disease","volume":"52","author":"Canbay","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.metabol.2022.155179_bb0120","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2174\/1567201818666210301095046","article-title":"A review on novel ligand targeted delivery for cardiovascular disorder","volume":"18","author":"Jaiswal","year":"2021","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.metabol.2022.155179_bb0125","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.atherosclerosis.2008.09.012","article-title":"Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome","volume":"204","author":"Kim","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2022.155179_bb0130","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.2337\/diacare.27.10.2498","article-title":"Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation","volume":"27","author":"Targher","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2022.155179_bb0135","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/ajh.2010.144","article-title":"Increased arterial stiffness and impaired endothelial function in nonalcoholic fatty liver disease: a pilot study","volume":"23","author":"Vlachopoulos","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.metabol.2022.155179_bb0140","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.atherosclerosis.2010.01.049","article-title":"Coronary flow reserve is impaired in patients with nonalcoholic fatty liver disease: association with liver fibrosis","volume":"211","author":"Yilmaz","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2022.155179_bb0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.20781","article-title":"Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease","volume":"42","author":"Villanova","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2022.155179_bb0150","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hep.25593","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery calcification","volume":"56","author":"Kim","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2022.155179_bb0155","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1136\/gut.2011.242016","article-title":"Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease","volume":"60","author":"Wong","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2022.155179_bb0160","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12872-016-0212-8","article-title":"Non alcoholic fatty liver disease increases the mortality from acute coronary syndrome: an observational study from Sri Lanka","volume":"16","author":"Perera","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.metabol.2022.155179_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088371","article-title":"Nonalcoholic fatty liver disease is associated with aortic valve sclerosis in patients with type 2 diabetes mellitus","volume":"9","author":"Bonapace","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155179_bb0170","article-title":"Association between noninvasive fibrosis markers and cardio-vascular organ damage among adults with hepatic steatosis","volume":"9","author":"Sesti","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155179_bb0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/BF03345421","article-title":"Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive type 2 diabetic individuals","volume":"35","author":"Mantovani","year":"2012","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.metabol.2022.155179_bb0180","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.echo.2011.09.018","article-title":"Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: a study validated with computed tomography","volume":"25","author":"Lai","year":"2012","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.metabol.2022.155179_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135329","article-title":"Nonalcoholic fatty liver disease is independently associated with early left ventricular diastolic dysfunction in patients with type 2 diabetes","volume":"10","author":"Mantovani","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155179_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142937","article-title":"Non-Alcoholic Fatty Liver Disease as a Predictor of Atrial Fibrillation in Middle-Aged Population (OPERA Study)","volume":"10","author":"K\u00e4r\u00e4j\u00e4m\u00e4ki","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155179_bb0195","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.numecd.2014.01.005","article-title":"Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes","volume":"24","author":"Targher","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.metabol.2022.155179_bb0200","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.2337\/dc16-0091","article-title":"Nonalcoholic fatty liver disease is associated with ventricular arrhythmias in patients with type 2 diabetes referred for clinically indicated 24-hour holter monitoring","volume":"39","author":"Mantovani","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2022.155179_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185459","article-title":"Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus","volume":"12","author":"Mantovani","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155179_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173398","article-title":"Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure","volume":"12","author":"Valbusa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155179_bb0215","doi-asserted-by":"crossref","first-page":"13306","DOI":"10.3748\/wjg.v20.i37.13306","article-title":"Nonalcoholic fatty liver disease and vascular disease: state-of-the-art","volume":"20","author":"Fargion","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2022.155179_bb0220","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2022.155179_bb0225","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2022.155179_bb0230","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2022.155179_bb0235","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2022.155179_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136822","article-title":"Dysregulated hepatic methionine metabolism drives homocysteine elevation in diet-induced nonalcoholic fatty liver disease","volume":"10","author":"Pacana","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155179_bb0245","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1476-511X-13-100","article-title":"Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile","volume":"13","author":"Corey","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2022.155179_bb0250","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","article-title":"Nonalcoholic fatty liver disease and serum lipoproteins: the multi-ethnic study of atherosclerosis","volume":"227","author":"DeFilippis","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2022.155179_bb0255","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/PAS.0b013e3182254283","article-title":"Centrizonal arteries and microvessels in nonalcoholic steatohepatitis","volume":"35","author":"Gill","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.metabol.2022.155179_bb0260","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2012.258","article-title":"The role of hepatokines in metabolism","volume":"9","author":"Stefan","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2022.155179_bb0265","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ijms18010008","article-title":"Metabolic adaptation in obesity and type II diabetes: myokines, adipokines and hepatokines","volume":"18","author":"Oh","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2022.155179_bb0270","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003101","article-title":"Cardiac-secreted factors as peripheral metabolic regulators and potential disease biomarkers","volume":"5","author":"Dewey","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2022.155179_bb0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.coph.2020.06.005","article-title":"Metabolic adaptations after bariatric surgery: adipokines, myokines and hepatokines","volume":"52","author":"Faramia","year":"2020","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.metabol.2022.155179_bb0280","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2022.155179_bb0285","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2022.155179_bb0290","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/hep.20920","article-title":"Insulin resistance: a metabolic pathway to chronic liver disease","volume":"42","author":"Bugianesi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2022.155179_bb0295","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1172\/JCI45887","article-title":"Adipose tissue remodeling and obesity","volume":"121","author":"Sun","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2022.155179_bb0300","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.metabol.2014.09.001","article-title":"Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients","volume":"63","author":"Wree","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155179_bb0305","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4239\/wjd.v6.i4.548","article-title":"Adipose tissue fibrosis","volume":"6","author":"Buechler","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1016\/j.metabol.2022.155179_bb0310","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/21623945.2021.1982164","article-title":"Association of cell death mechanisms and fibrosis in visceral white adipose tissue with pathological alterations in the liver of morbidly obese patients with NAFLD","volume":"10","author":"Leven","year":"2021","journal-title":"Adipocyte"},{"key":"10.1016\/j.metabol.2022.155179_bb0315","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/0003319719844933","article-title":"The nonalcoholic fatty liver disease fibrosis score is related to epicardial fat thickness and complexity of coronary artery disease","volume":"71","author":"Turan","year":"2020","journal-title":"Angiology"},{"key":"10.1016\/j.metabol.2022.155179_bb0320","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.3390\/ijms20235989","article-title":"Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk","volume":"20","author":"Villasante Fricke","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2022.155179_bb0325","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/hep.31608","article-title":"Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: the Framingham heart study","volume":"73","author":"Long","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2022.155179_bb0330","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3389\/fimmu.2019.01587","article-title":"Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.metabol.2022.155179_bb0335","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.metabol.2022.155179_bb0340","series-title":"Muscle: fundamental biology and mechanisms of disease","first-page":"127","article-title":"Communication in the heart: cardiokines as mediators of a molecular social network","volume":"Volume 1","author":"Doroudgar","year":"2012"},{"key":"10.1016\/j.metabol.2022.155179_bb0345","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.3390\/ijms21218372","article-title":"Adipokines, myokines, and cardiokines: the role of nutritional interventions","volume":"21","author":"Senesi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2022.155179_bb0350","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/prca.201100052","article-title":"Adipokines: a treasure trove for the discovery of biomarkers for metabolic disorders","volume":"6","author":"Lehr","year":"2012","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.metabol.2022.155179_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002322","article-title":"A phenomics-based strategy identifies loci on APOC1, BRAP, and PLCG1 associated with metabolic syndrome phenotype domains","volume":"7","author":"Avery","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/j.metabol.2022.155179_bb0360","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/db10-1011","article-title":"A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium","volume":"60","author":"Kraja","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2022.155179_bb0365","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/CIRCGENETICS.113.000386","article-title":"Analysis of metabolic syndrome components in >15 000 african americans identifies pleiotropic variants: results from the population architecture using genomics and epidemiology study","volume":"7","author":"Carty","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.metabol.2022.155179_bb0370","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/CIRCGENETICS.111.961482","article-title":"Genome-wide screen for metabolic syndrome susceptibility loci reveals strong lipid gene contribution but no evidence for common genetic basis for clustering of metabolic syndrome traits","volume":"5","author":"Kristiansson","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.metabol.2022.155179_bb0375","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2022.155179_bb0380","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2022.155179_bb0385","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1053\/j.gastro.2016.01.032","article-title":"The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of european descent","volume":"150","author":"Mancina","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2022.155179_bb0390","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.CIR.76.3.504","article-title":"Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis","volume":"76","author":"Goldstein","year":"1987","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2022.155179_bb0395","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","article-title":"Lysosomal acid lipase deficiency \u2013 an under-recognized cause of dyslipidaemia and liver dysfunction","volume":"235","author":"Reiner","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2022.155179_bb0400","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hep.26319","article-title":"Intestinal microbiota in patients with nonalcoholic fatty liver disease","volume":"58","author":"Mouzaki","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2022.155179_bb0405","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.1016\/j.metabol.2019.05.006","article-title":"Helicobacter pylori infection and nonalcoholic fatty liver disease: are the four meta-analyses favoring an intriguing association pointing to the right direction?","volume":"96","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2022.155179_bb0410","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000246970","article-title":"Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA\/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in japanese elderly with type 2 diabetes mellitus","volume":"56","author":"Sakurai","year":"2010","journal-title":"Gerontology"},{"key":"10.1016\/j.metabol.2022.155179_bb0415","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11357-016-9884-3","article-title":"Obesity and related consequences to ageing","volume":"38","author":"Jura","year":"2016","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.metabol.2022.155179_bb0420","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/pharmaceutics13122009","article-title":"Transcriptome-wide analysis of human liver reveals age-related differences in the expression of select functional gene clusters and evidence for a PPP1R10-governed \u2018Aging Cascade\u2019","volume":"13","author":"Schreiter","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.metabol.2022.155179_bb0425","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1900\/RDS.2017.14.279","article-title":"Association between socioeconomic determinants and the metabolic syndrome in the german health interview and examination survey for adults (DEGS1) \u2013 a mediation analysis","volume":"14","author":"Montano","year":"2017","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.metabol.2022.155179_bb0430","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/oemed-2018-105104","article-title":"Association between night-shift work, sleep quality and metabolic syndrome","volume":"75","author":"Lim","year":"2018","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.metabol.2022.155179_bb0435","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3390\/ijms17122082","article-title":"Pathophysiology of non alcoholic fatty liver disease","volume":"17","author":"Petta","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2022.155179_bb0440","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3390\/ijms20081948","article-title":"Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: an overview","volume":"20","author":"Marchisello","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2022.155179_bb0445","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.3390\/cells9112458","article-title":"Significance of simple steatosis: an update on the clinical and molecular evidence","volume":"9","author":"Mazzolini","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.metabol.2022.155179_bb0450","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa0707402","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease","volume":"359","author":"Zacho","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2022.155179_bb0455","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.2337\/diabetes.50.10.2199","article-title":"Resistin \/ Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans","volume":"50","author":"Savage","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2022.155179_bb0460","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1253\/circj.71.460","article-title":"Serum resistin is associated with high risk in patients with congestive heart failure \u2013 a novel link between metabolic signals and heart failure","volume":"71","author":"Takeishi","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.metabol.2022.155179_bb0465","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/157016110790226679","article-title":"Visfatin\/PBEF and atherosclerosis-related diseases","volume":"8","author":"Filippatos","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.metabol.2022.155179_bb0470","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cyto.2011.10.015","article-title":"Interpretation of elevated plasma visfatin concentrations in patients with ST-elevation myocardial infarction","volume":"57","author":"Lu","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.metabol.2022.155179_bb0475","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1373\/clinchem.2005.062463","article-title":"Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome","volume":"52","author":"Xu","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2022.155179_bb0480","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/01.HYP.31.1.409","article-title":"Chronic leptin infusion increases arterial pressure","volume":"31","author":"Shek","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2022.155179_bb0485","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.2337\/diabetes.48.9.1787","article-title":"Sympathetic activation of leptin via the ventromedial hypothalamus: leptin-induced increase in catecholamine secretion","volume":"48","author":"Satoh","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2022.155179_bb0490","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.amjcard.2007.02.088","article-title":"Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population","volume":"100","author":"Sierra-Johnson","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2022.155179_bb0495","doi-asserted-by":"crossref","first-page":"T17","DOI":"10.1530\/JOE-12-0232","article-title":"Role of adipokines in cardiovascular disease","volume":"216","author":"Mattu","year":"2013","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2022.155179_bb0500","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/HYPERTENSIONAHA.107.086835","article-title":"Hypoadiponectinemia as a predictor for the development of hypertension: a 5-year prospective study","volume":"49","author":"Chow","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2022.155179_bb0505","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jash.2014.07.033","article-title":"Role of RAAS and adipokines in cardiovascular protection: effect of different doses of angiotensin II receptor blocker on adipokines level in hypertensive patients","volume":"8","author":"Hass","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.metabol.2022.155179_bb0510","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1042\/CS20150009","article-title":"Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K\/Akt pathway in type 2 diabetic mice and hepatocytes","volume":"129","author":"Liu","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.metabol.2022.155179_bb0515","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/ijo.2015.199","article-title":"Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway","volume":"40","author":"Xin","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2022.155179_bb0520","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/01.CIR.0000091235.94914.75","article-title":"Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction","volume":"108","author":"Chen","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2022.155179_bb0525","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ejheart.2005.10.007","article-title":"Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure","volume":"8","author":"Chong","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.metabol.2022.155179_bb0530","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijcard.2016.11.215","article-title":"Apelin\/APJ system: a bifunctional target for cardiac hypertrophy","volume":"230","author":"Lu","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.metabol.2022.155179_bb0535","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2020.10.030","article-title":"Hepatokines and adipokines in NASH-related hepatocellular carcinoma","volume":"74","author":"Kucukoglu","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2022.155179_bb0540","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/HCO.0b013e328354829c","article-title":"Nonalcoholic fatty liver disease and vascular risk","volume":"27","author":"Bhatia","year":"2012","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.metabol.2022.155179_bb0545","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review","volume":"73","author":"Stahl","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155179_bb0550","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000341248","article-title":"The association between nonalcoholic fatty liver disease, metabolic syndrome and arterial stiffness in nondiabetic, nonhypertensive individuals","volume":"123","author":"Kim","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.metabol.2022.155179_bb0555","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","article-title":"Long-term follow-up of patients with nonalcoholic fatty liver","volume":"7","author":"Rafiq","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155179_bb0560","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.atherosclerosis.2014.10.004","article-title":"Arterial stiffness in patients with non-alcoholic fatty liver disease is related to fibrosis stage and epicardial adipose tissue thickness","volume":"237","author":"Sunbul","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2022.155179_bb0565","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","article-title":"Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus","volume":"52","author":"Rijzewijk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155179_bb0570","doi-asserted-by":"crossref","first-page":"22309","DOI":"10.3390\/ijms151222309","article-title":"A genetic polymorphism in RBP4 is associated with coronary artery disease","volume":"15","author":"Wan","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2022.155179_bb0575","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1161\/CIRCULATIONAHA.108.814418","article-title":"Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke","volume":"118","author":"Weikert","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2022.155179_bb0580","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.atherosclerosis.2009.05.018","article-title":"High plasma fetuin-a is associated with increased carotid intima-media thickness in a middle-aged population","volume":"207","author":"Rittig","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2022.155179_bb0585","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2337\/dc12-1591","article-title":"Fetuin-a, type 2 diabetes, and risk of cardiovascular disease in older adults: the cardiovascular health study","volume":"36","author":"Jensen","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2022.155179_bb0590","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/CS20120542","article-title":"Fetuin-a mRNA expression is elevated in NASH compared with NAFL patients","volume":"125","author":"Kahraman","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.metabol.2022.155179_bb0595","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12944-018-0866-6","article-title":"The association between hepcidin and arterial stiffness in a community-dwelling population","volume":"17","author":"Wang","year":"2018","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2022.155179_bb0600","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/ATVBAHA.118.312215","article-title":"Hepcidin deficiency protects against atherosclerosis","volume":"39","author":"Malhotra","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2022.155179_bb0605","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/ATVBAHA.113.301599","article-title":"Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors","volume":"33","author":"Chow","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2022.155179_bb0610","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1475-2840-12-124","article-title":"Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease","volume":"12","author":"Shen","year":"2013","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metabol.2022.155179_bb0615","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1540267","article-title":"Physiological and pharmacological roles of FGF21 in cardiovascular diseases","volume":"2016","author":"Cheng","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.metabol.2022.155179_bb0620","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.molmed.2010.12.003","article-title":"The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart","volume":"17","author":"Doroudgar","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.metabol.2022.155179_bb0625","doi-asserted-by":"crossref","unstructured":"K Damman JM. Testani The kidney in heart failure: an update. Eur Heart J 201;36:1437-44. doi: 10.1093\/eurheartj\/ehv010.","DOI":"10.1093\/eurheartj\/ehv010"},{"key":"10.1016\/j.metabol.2022.155179_bb0630","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.atherosclerosis.2013.10.030","article-title":"Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology","volume":"232","author":"Loria","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2022.155179_bb0635","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apha.12246","article-title":"Adipose tissue and its role in organ crosstalk","volume":"210","author":"Romacho","year":"2014","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.metabol.2022.155179_bb0640","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1083\/jcb.201409063","article-title":"The cell biology of fat expansion","volume":"208","author":"Rutkowski","year":"2015","journal-title":"J Cell Biol"},{"key":"10.1016\/j.metabol.2022.155179_bb0645","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jjcc.2014.10.012","article-title":"Interleukin-18-induced atherosclerosis involves CD36 and NF-\u03baB crosstalk in apo E-\/- mice","volume":"66","author":"Bhat","year":"2015","journal-title":"J Cardiol"},{"key":"10.1016\/j.metabol.2022.155179_bb0650","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/met.2015.0130","article-title":"Combined elevated levels of the proinflammatory cytokines IL-18 and IL-12 are associated with clinical events in patients with coronary artery disease: an observational study","volume":"14","author":"Opstad","year":"2016","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.metabol.2022.155179_bb0655","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.cmet.2008.10.011","article-title":"Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism","volume":"8","author":"Kumar","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2022.155179_bb0660","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/molecules25030549","article-title":"Adropin as a fat-burning hormone with multiple functions \u2013 review of a decade of research","volume":"25","author":"Jasaszwili","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.metabol.2022.155179_bb0665","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11010-013-1660-4","article-title":"Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes","volume":"380","author":"Aydin","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.metabol.2022.155179_bb0670","doi-asserted-by":"crossref","first-page":"H238","DOI":"10.1152\/ajpheart.00449.2020","article-title":"Adropin: a hepatokine modulator of vascular function and cardiac fuel metabolism","volume":"320","author":"Mushala","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.metabol.2022.155179_bb0675","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA119.008967","article-title":"The peptide hormone adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity","volume":"294","author":"Gao","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2022.155179_bb0680","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13108","article-title":"Adropin as a potential mediator of the metabolic system-autonomic nervous system-chronobiology axis: implementing a personalized signature-based platform for chronotherapy","volume":"22","author":"Kolben","year":"2021","journal-title":"Obes Rev"},{"key":"10.1016\/j.metabol.2022.155179_bb0685","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/oby.2012.31","article-title":"Adropin deficiency is associated with increased adiposity and insulin resistance","volume":"20","author":"Ganesh Kumar","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2022.155179_bb0690","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1096\/fj.08-114991","article-title":"Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin","volume":"23","author":"Wong","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2022.155179_bb0695","doi-asserted-by":"crossref","first-page":"18965","DOI":"10.1074\/jbc.M112.357939","article-title":"CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism","volume":"287","author":"Kambara","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2022.155179_bb0700","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00395-012-0315-z","article-title":"Inhibition of CTRP9, a novel and cardiac-abundantly expressed cell survival molecule, by TNF\u03b1-initiated oxidative signaling contributes to exacerbated cardiac injury in diabetic mice","volume":"108","author":"Su","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.metabol.2022.155179_bb0705","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mce.2015.09.027","article-title":"C1q\/TNF-related protein 9 (CTRP9) attenuates hepatic steatosis via the autophagy-mediated inhibition of endoplasmic reticulum stress","volume":"417","author":"Jung","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2022.155179_bb0710","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2016.20","article-title":"Crosstalk between the heart and peripheral organs in heart failure","volume":"48","author":"Jahng","year":"2016","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.metabol.2022.155179_bb0715","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1159\/000510600","article-title":"Lipoprotein and metabolic profiles indicate similar cardiovascular risk of liver steatosis and NASH","volume":"102","author":"Gottlieb","year":"2021","journal-title":"Digestion"},{"key":"10.1016\/j.metabol.2022.155179_bb0720","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nature14541","article-title":"Probabilistic machine learning and artificial intelligence","volume":"521","author":"Ghahramani","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2022.155179_bb0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062439","article-title":"Novel algorithm for non-invasive assessment of fibrosis in NAFLD","volume":"8","author":"Sowa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155179_bb0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101444","article-title":"Non-invasive separation of alcoholic and non-alcoholic liver disease with predictive modeling","volume":"9","author":"Sowa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155179_bb0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214436","article-title":"Non-invasive assessment of NAFLD as systemic disease \u2013 a machine learning perspective","volume":"14","author":"Canbay","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155179_bb0740","doi-asserted-by":"crossref","DOI":"10.1016\/j.artmed.2019.101706","article-title":"The virtual doctor: an interactive clinical-decision-support system based on deep learning for non-invasive prediction of diabetes","volume":"100","author":"Sp\u00e4nig","year":"2019","journal-title":"Artif Intell Med"},{"key":"10.1016\/j.metabol.2022.155179_bb0745","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/s42255-019-0145-5","article-title":"Inter-organ cross-talk in metabolic syndrome","volume":"1","author":"Priest","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/j.metabol.2022.155179_bb0750","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/heartjnl-2017-311198","article-title":"Machine learning in cardiovascular medicine: are we there yet?","volume":"104","author":"Shameer","year":"2018","journal-title":"Heart"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522000579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049522000579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:30:00Z","timestamp":1758429000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049522000579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":150,"alternative-id":["S0026049522000579"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155179","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards harnessing the value of organokine crosstalk to predict the risk for cardiovascular disease in non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155179"}}